Eric Warren insider trades

Open-market stock purchases and sales by Eric Warren, Chief Commercial Officer at Mineralys Therapeutics, Inc, from SEC Form 4 filings since Mar 14, 2022.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -58%.

Recent trades

DateStockTradeValue
Sep 21, 2026MLYS Mineralys Therapeutics, IncBought (not open market)—
Sep 21, 2026MLYS Mineralys Therapeutics, IncSold$209K
Aug 21, 2026MLYS Mineralys Therapeutics, IncSold$193K
Aug 21, 2026MLYS Mineralys Therapeutics, IncBought (not open market)—
Jul 21, 2026MLYS Mineralys Therapeutics, IncSold$200K
Jul 21, 2026MLYS Mineralys Therapeutics, IncBought (not open market)—
Jun 26, 2026MLYS Mineralys Therapeutics, IncSold$2.7M
Jun 26, 2026MLYS Mineralys Therapeutics, IncBought (not open market)—

Companies traded

  • MLYS Mineralys Therapeutics, Inc: 4 sales, last Sep 21, 2026
  • ESPR Esperion Therapeutics, Inc: 1 buy, 26 sales, last Apr 17, 2025

Get free alerts when Eric Warren files a new trade →